搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O45:K1 Thiosulfate sulfurtransferase glpE (glpE) CSB-YP486067EOK
CSB-EP486067EOK
CSB-BP486067EOK
CSB-MP486067EOK
CSB-EP486067EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 UPF0133 protein ybaB (ybaB) CSB-YP486068EOK
CSB-EP486068EOK
CSB-BP486068EOK
CSB-MP486068EOK
CSB-EP486068EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Ureidoglycolate hydrolase (allA) CSB-YP486069EOK
CSB-EP486069EOK
CSB-BP486069EOK
CSB-MP486069EOK
CSB-EP486069EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Multidrug resistance protein MdtA (mdtA) CSB-YP486070EOK
CSB-EP486070EOK
CSB-BP486070EOK
CSB-MP486070EOK
CSB-EP486070EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 D-tagatose-1,6-bisphosphate aldolase subunit GatY (gatY) CSB-YP486071EOK
CSB-EP486071EOK
CSB-BP486071EOK
CSB-MP486071EOK
CSB-EP486071EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Glyoxylate/hydroxypyruvate reductase B (ghrB) CSB-YP486072EOK
CSB-EP486072EOK
CSB-BP486072EOK
CSB-MP486072EOK
CSB-EP486072EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Apo-citrate lyase phosphoribosyl-dephospho-CoA transferase (citX) CSB-YP486073EOK
CSB-EP486073EOK
CSB-BP486073EOK
CSB-MP486073EOK
CSB-EP486073EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Pyrimidine-specific ribonucleoside hydrolase rihB (rihB) CSB-YP486074EOK
CSB-EP486074EOK
CSB-BP486074EOK
CSB-MP486074EOK
CSB-EP486074EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Ecotin (eco) CSB-YP486075EOK
CSB-EP486075EOK
CSB-BP486075EOK
CSB-MP486075EOK
CSB-EP486075EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Mannitol-1-phosphate 5-dehydrogenase (mtlD) CSB-YP486076EOK
CSB-EP486076EOK
CSB-BP486076EOK
CSB-MP486076EOK
CSB-EP486076EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 ADP-L-glycero-D-manno-heptose-6-epimerase (hldD) CSB-YP486077EOK
CSB-EP486077EOK
CSB-BP486077EOK
CSB-MP486077EOK
CSB-EP486077EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Orotate phosphoribosyltransferase (pyrE) CSB-YP486078EOK
CSB-EP486078EOK
CSB-BP486078EOK
CSB-MP486078EOK
CSB-EP486078EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 UPF0250 protein ybeD (ybeD) CSB-YP486079EOK
CSB-EP486079EOK
CSB-BP486079EOK
CSB-MP486079EOK
CSB-EP486079EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Glucosamine-6-phosphate deaminase (nagB) CSB-YP486080EOK
CSB-EP486080EOK
CSB-BP486080EOK
CSB-MP486080EOK
CSB-EP486080EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Protein TolB (tolB) CSB-YP486081EOK
CSB-EP486081EOK
CSB-BP486081EOK
CSB-MP486081EOK
CSB-EP486081EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase (arnB) CSB-YP486082EOK
CSB-EP486082EOK
CSB-BP486082EOK
CSB-MP486082EOK
CSB-EP486082EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (menD) CSB-YP486083EOK
CSB-EP486083EOK
CSB-BP486083EOK
CSB-MP486083EOK
CSB-EP486083EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 UPF0207 protein yfbR (yfbR) CSB-YP486084EOK
CSB-EP486084EOK
CSB-BP486084EOK
CSB-MP486084EOK
CSB-EP486084EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 UPF0115 protein yfcN (yfcN) CSB-YP486085EOK
CSB-EP486085EOK
CSB-BP486085EOK
CSB-MP486085EOK
CSB-EP486085EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 50S ribosomal protein L34 (rpmH) CSB-YP486086EOK
CSB-EP486086EOK
CSB-BP486086EOK
CSB-MP486086EOK
CSB-EP486086EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>